Patents by Inventor Lai-Cheng CHIN

Lai-Cheng CHIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified release pharmaceutical composition and method for the treatment of mental disorders
    Patent number: 11759471
    Abstract: The present invention is concerned with a modified release pharmaceutical composition comprising an effective amount of at least one antipsychotic agent so that the antipsychotic agent(s) are released in such a manner to better accord with physiological and chronotherapeutic requirements of patients.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: September 19, 2023
    Assignee: MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
    Inventors: Shih-Ku Lin, Chih-Chiang Yang, Tse-Ching Lin, Lai-Cheng Chin, Pei Hsuan Ho
  • Oral composition and methods for manufacturing the same and treatment
    Patent number: 11752104
    Abstract: An oral composition includes an immediate-release pharmaceutical admixture and an extended-release pharmaceutical admixture. The immediate-release pharmaceutical admixture includes a first portion of an active ingredient and a first portion of a hydrophilic dispersant, in which the active ingredient is substantially insoluble in water. The extended-release pharmaceutical admixture includes a controlled-release material, a second portion of the active ingredient, and a second portion of the hydrophilic dispersant, wherein the second portion of the active ingredient and the second portion of the hydrophilic dispersant are mixed in the controlled-release material, wherein the active ingredient is present as a nanoparticle in the immediate-release pharmaceutical admixture and the extended-release pharmaceutical admixture.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: September 12, 2023
    Assignee: MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND
    Inventors: Meng-Kun Tsai, Chih-Chiang Yang, Wen-Che Wang, Tzu-Yu Chien, Chien-Chia Wu, Lai-Cheng Chin
  • Oral pH independent dosage formulation for treating neurodegenerative disorders
    Patent number: 10894023
    Abstract: Disclosed herein is an oral dosage formulation suitable for treating a neurodegenerative disorder. The oral dosage formulation contains both sustained-release and immediate-release drugs. The sustained-release drug in the oral dosage formulation is memantine, and the immediate-release drug in the oral dosage formulation is donepezil and/or memantine, and the formulation is characterized in having a pH-independent dissolution profile of memantine at a pH range from about 1.0 to about 7.0.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: January 19, 2021
    Assignee: CENTER LABORATORIES, INC.
    Inventors: Meng-Ju Lee, Shu-Hsien Chang, Chih-Chiang Yang, Yuan-Chih Le, Tse-Ching Lin, Ko-Chiang Chen, Lai-Cheng Chin, Tai-Yin Ke, Pei-Ying Liao
  • ORAL COMPOSITION AND METHODS FOR MANUFACTURING THE SAME AND TREATMENT
    Publication number: 20200375901
    Abstract: An oral composition includes an immediate-release pharmaceutical admixture and an extended-release pharmaceutical admixture. The immediate-release pharmaceutical admixture includes a first portion of an active ingredient and a first portion of a hydrophilic dispersant, in which the active ingredient is substantially insoluble in water. The extended-release pharmaceutical admixture includes a controlled-release material, a second portion of the active ingredient, and a second portion of the hydrophilic dispersant, wherein the second portion of the active ingredient and the second portion of the hydrophilic dispersant are mixed in the controlled-release material, wherein the active ingredient is present as a nanoparticle in the immediate-release pharmaceutical admixture and the extended-release pharmaceutical admixture.
    Type: Application
    Filed: May 29, 2020
    Publication date: December 3, 2020
    Inventors: Meng-Kun TSAI, Chih-Chiang YANG, Wen-Che WANG, Tzu-Yu CHIEN, Chien-Chia WU, Lai-Cheng CHIN
  • MODIFIED RELEASE PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF MENTAL DISORDERS
    Publication number: 20200323875
    Abstract: The present invention is concerned with a modified release pharmaceutical composition comprising an effective amount of at least one antipsychotic agent so that the antipsychotic agent(s) are released in such a manner to better accord with physiological and chronotherapeutic requirements of patients.
    Type: Application
    Filed: April 10, 2020
    Publication date: October 15, 2020
    Inventors: Shih-Ku LIN, Chih-Chiang YANG, Tse-Ching LIN, Lai-Cheng CHIN, Pei Hsuan HO
  • ORAL pH INDEPENDENT DOSAGE FORMULATION FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20190388340
    Abstract: Disclosed herein is an oral dosage formulation suitable for treating a neurodegenerative disorder. The oral dosage formulation contains both sustained-release and immediate-release drugs. The sustained-release drug in the oral dosage formulation is memantine, and the immediate-release drug in the oral dosage formulation is donepezil and/or memantine, and the formulation is characterized in having a pH-independent dissolution profile of memantine at a pH range from about 1.0 to about 7.0.
    Type: Application
    Filed: June 20, 2019
    Publication date: December 26, 2019
    Applicants: Center Laboratories, Inc., Medical and Pharmaceutical Industry Technology and Development Center
    Inventors: Meng-Ju LEE, Shu-Hsien CHANG, Chih-Chiang YANG, Yuan-Chih LE, Tse-Ching LIN, Ko-Chiang CHEN, Lai-Cheng CHIN, Tai-Yin KE, Pei-Ying LIAO